重组GH疗法:儿童预期结果,方法和监测
Maria Elisa Amodeo1, Cesare Morgante2, Valentina Pampanini3
1Endocrinology and Diabetes Unit, IRCCS "Bambino Gesù" Children's Hospital, Rome, Italy, mariaelisaamodeo@gmail.com.
Frontiers of hormone research
|November 25, 2024
概括
重组人体生长激素 (rhGH) 有效地治疗儿童的生长激素缺乏症 (GHD),改善身材和代谢健康. 长期的安全性令人放心,新配方增强了患者的坚持.
科学领域:
- 儿科内分泌学 儿科内分泌学
- 药理学 药理学是指药理学的学科.
- 生物技术是生物技术.
背景情况:
- 增长激素 (GH) 治疗从垂体衍生的演变为重组人体GH (rhGH).
- rhGH已被批准用于GH缺乏症 (GHD) 和其他临床疾病.
- rhGH在改善GHD患者的矮身和代谢健康方面表现出有效性.
研究的目的:
- 审查rhGH在儿科GHD中的指示,疗效和安全性.
- 讨论GH治疗的不断变化的格局,包括新的配方.
主要方法:
- 关于儿科GHD的rhGH治疗现有文献的审查.
- 从临床研究中获得的疗效和安全数据的分析.
- 讨论长期安全监测和新的rhGH配方.
主要成果:
- 在小儿GHD中,rhGH治疗对矮身有效.
- 观察到对代谢和骨健康的有益影响.
- 对于孤立的GHD的长期安全数据令人放心.
- 对于非GHD用途和特定条件,需要持续监测.
结论:
- rhGH 是对儿科GHD的成熟治疗方法,具有良好的疗效和安全性.
- 新的长效配方旨在改善患者的坚持和减少治疗负担.
- 持续的研究和监测对于优化rhGH疗法至关重要.
相关概念视频
00:59Gene Therapy
25.2K
Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be...
25.2K
01:16Insulin: Dosing Regimen and Adverse Effects
145
Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
145